Back to search

France· FR:60272948

SOMATOSTATINE VIATRIS 3 mg/1 ml, poudre et solvant pour solution à diluer pour perfusion

A somatostatin product containing somatostatine, registered in France by VIATRIS SANTE. The same ATC class is registered in 7 of our 19 countries.

ATC H01CB01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSOMATOSTATINE VIATRIS 3 mg/1 ml, poud…ATCH01CB01REGISTER NO.FR:60272948PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Somatostatin is registered in 7 of 19 countries.

Countries holding a registration under ATC H01CB01 (somatostatin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose

Somatostatin · ATC H01CB01

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SOMATOSTATINE
Manufacturer
VIATRIS SANTE
Country
France (FR)
ATC code
H01CB01
ATC class
Somatostatin
Defined daily dose
6 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400957714178
    1 flacon(s) en verre de poudre - 1 ampoule(s) en verre de solvant de 1 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Somatostatin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All somatostatin products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Somatin, Somatostatin Eumedica
  • Belgium · Somatostatine Belpharma, Somatostatine Eumedica
  • Bulgaria · Соматостатин Бандалис, Соматостатин Лиомарк
  • Cyprus · Somatostatine Eumedica
  • Czechia · Somatostatin Eumedica, Somatostatin Rompharm
  • Germany · Somatostatin Inresa, Somatostatin Lyomark 3 Mg
  • Spain · Somatostatina Gp-Pharm, Somatostatina Normon
  • Greece · Atostan, Eklivan
  • Italy · Resurmide, Somatostatina Hikma
  • Luxembourg · Somatostatine Eumedica, Somatostatine-Eumedica
  • Poland · Somatostatin Eumedica
  • Portugal · Somatostatina Hikma, Somatostatina Normon
  • Romania · Somatostatină Rompharm
  • Slovenia · Somatostatin Eumedica

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/acbf7969-6fb4-48b9-a93f-389860dc241c
GET /v1/drugs/acbf7969-6fb4-48b9-a93f-389860dc241c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60272948",
  "date_amm": "2010-05-19",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SOMATOSTATINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about somatostatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.